Related Experiment Videos
Early iron overload in beta-thalassaemia major: when to start chelation therapy?
Insights
Children with beta-thalassaemia major experience severe iron overload even with few transfusions. The desferrioxamine test effectively assesses chelation therapy response in young children, enabling early intervention to prevent iron overload harm.
Area of Science:
- Pediatric Hematology
- Iron Metabolism Disorders
Background:
- Beta-thalassaemia major requires intensive transfusions, leading to iron overload.
- Iron overload poses significant health risks in children with beta-thalassaemia major.
Purpose of the Study:
- To assess iron overload status in young children with beta-thalassaemia major.
- To evaluate the utility of the desferrioxamine test in assessing chelation therapy response.
Main Methods:
- Measured serum iron, transferrin saturation, serum ferritin, and non-transferrin iron.
- Assessed subcutaneous desferrioxamine-induced urinary iron excretion in 28 children (11-48 months).
Main Results:
- Children showed severe iron overload, indicated by high serum ferritin and urinary iron excretion.
- The desferrioxamine test proved useful in assessing treatment response, even in very young patients.
Conclusions:
- Early assessment of iron overload is crucial for children with beta-thalassaemia major.
- The desferrioxamine test facilitates early initiation of chelation therapy to prevent complications.
Abstract:
Twenty-eight children with beta-thalassaemia major aged between 11 and 48 months were given intensive transfusions. Serum iron, transferrin saturation, serum ferritin, non-transferrin iron, and subcutaneous desferrioxamine-induced urinary iron excretion were measured. The results showed that even children with a limited number of transfusions had severe iron overload as indicated, in particular, by the raised serum ferritin levels and the high excretion rates after subcutaneous infusion of desferrioxamine. The desferrioxamine test was useful, even in very young children, in assessing response to chelation therapy thus enabling such treatment to be started early to prevent harm from iron overload.